Expression of p53 in recurrent nodal metastasis from nasopharyngeal carcinoma (NPC)

European Journal of Surgical Oncology

Volumn 23, Issue 5, 1997, Pages 415-418

  Chow, Louis W C ^a   Khoo, Ui S ^a   Yuen, Anthony P W ^a   Wei, William I ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Nasopharyngeal carcinoma; p53 expression; Recurrent nodal metastasis

Indexed keywords

MONOCLONAL ANTIBODY; PROTEIN P53;

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CANCER SURVIVAL; CERVICAL LYMPH NODE; CLINICAL ARTICLE; CLINICAL TRIAL; DIAGNOSTIC VALUE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MALE; NASOPHARYNX CARCINOMA; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; STAINING;

EID: 0030777925     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0748-7983(97)93721-5     Document Type: Article

References (17)

1. Muir C, Waterhouse J, Mack T, Powell J, Whelan S (eds). Cancer Incidence in Five Continents. Lyon, France: International Agency for Research on Cancer; 1987; 5:840-1. IARC Scientific Publication.
2. Fox R, Graham WP III. Carcinoma of the nasopharynx and posterior pharyngeal wall. Surg Clin North Am 1986; 66:97-108.
3. Hsu MM, Tu SM. Nasopharyngeal carcinoma in Taiwan: clinical manifestations and results of therapy. Cancer 1983; 52: 362-8.
4. Zhang EP, Lian PG, Cai KL, et al. Radiation therapy of nasopharyngeal carcinoma; prognostic factors based on a 10-year follow-up of 1032 pateints. Int J Radiat Oncol Biol Phys 1989; 16: 301-5.
5. Wei WI, Ho CM, Wong MP, et al. Pathological basis of surgery in the management of postradiotherapy cervical metastasis in nasopharyngeal carcinoma. Arch Otolaryngol Head Neck Surg 1992; 118: 923-9.
6. Hollstein M, Sidransky D, Vogelstein B, Harris CC. p53 mutations in human cancers. Science 1991; 253: 49-53.
7. Lane DP, Benchimol S. p53: oncogene or anti-oncogene? Gene Dev 1990; 4: 1-8.
8. Sun Y, Hegamyer G, Cheng YJ, et al. An infrequent point mutation of the p53 gene in human nasopharyngeal carcinoma. Proc Natl Acad Sci USA 1992; 89: 6516-20.
9. Spruck CH, Tsai YC, Huang DP, et al. Absence of p53 gene mutations in primary nasopharyngeal carcinomas. Cancer Res 1992; 52: 4787-90.
10. Porter MJ, Field JK, Lee JC, et al. Detection of the tumour suppressor gene p53 in nasopharyngeal carcinoma in Hong Kong Chinese. Anticancer Res 1994; 14(3B): 1357-60.
11. Lo KW, Mok CH, Huang DP, et al. p53 mutation in human nasopharyngeal carcinomas. Anticancer Res 1992; 12: 1957-64.
12. Effert P, McCoy R. Abdel-Hamid M. et al. Alterations of the p53 gene in nasopharyngeal carcinoma. J Virol 1992; 66: 3768-75.
13. Nasrin N, Taiba K, Hannan N, et al. A molecular study of EBV DNA and p53 mutations in nasopharyngeal carcinoma of Saudi Arab patients. Cancer Lett 1994; 82: 189-98.
14. Sun Y, Nakamura K, Wendel E, Colburn N. Progression toward tumour cell phenotype is enhanced by overexpression of a mutant p53 tumor-suppressor gene isolated from nasopharyngeal carcinoma. Proc Natl Acad Sci USA 1993; 90: 2827-31.
15. Sham JST, Wei WI, Kwan WH, et al. Nasopharyngeal carcinoma: pattern of tumour regression after radiotherapy. Cancer 1990; 65: 216-20.
16. Sheu LF, Chen A, Tseng HH, et al. Assessment of p53 expression in nasopharyngeal carcinoma. Hum Pathol 1995; 26: 380-6.
17. Lee JM, Berstein A. p53 mutations increase resitance to ionizing radiation. Proc Natl Acad Sci USA 1993; 90: 5742-6.